Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, lab study reveals

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, a new study in the laboratory reveals.

source https://www.sciencedaily.com/releases/2021/08/210806104405.htm